Search

everythinglearnresearchcommunity

for

Search:↓

Hair loss is common in autoimmune diseases and can be an early sign of the condition, often requiring prompt treatment to prevent permanent damage.

Frontal fibrosing alopecia often occurs after menopause, with delayed diagnosis and possible links to certain medications and conditions.

Granzyme B is important in autoimmune skin diseases and could be a new treatment target.

Antigen presenting cells around hair follicles are crucial in SLE-related hair loss.

An old recipe called "Champigny Saumure" might help treat a rare scalp condition.

The research found that male pattern hair loss is mostly genetic and involves hair thinning due to hormonal effects and changes in gene expression.

Understanding hair health and disorders is important for effective treatment.

Chronic burn scars may lead to scalp skin issues, so doctors should consider this when diagnosing.

A possible link exists between minimal change nephrotic syndrome and complete hair loss.

Frontal fibrosing alopecia in families shows similar signs to individual cases and may have a genetic link.

Dutasteride can stabilize hair loss in patients with frontal fibrosing alopecia, but its safety in women is unclear, so use it with caution.

Oral isotretinoína effectively stabilizes frontal fibrosing alopecia.

Many children with alopecia areata also have other autoimmune diseases.

Frontal Fibrosing Alopecia is a type of hair loss affecting mostly older women, with no agreed best treatment.

Stopping sunscreen use on the forehead led to hair regrowth in a woman with frontal fibrosing alopecia.

No effective treatment for frontal fibrosing alopecia was found, but oral 5-alpha-reductase inhibitors had the best response; for lichen planopilaris, topical corticosteroids were commonly used but had a high relapse rate.

FAGA diagnosis uses blood tests and trichoscopy, with treatments like topical minoxidil, oral anti-androgens, and hormone-modulating drugs.

Early diagnosis and treatment are crucial for preventing permanent hair loss in various scalp conditions, and while new treatments are promising, more research is needed to evaluate their effectiveness.

Frontal Fibrosing Alopecia's cause is unclear, affects mainly postmenopausal women, and current treatments focus on stopping hair loss rather than regrowth.

No treatment has been proven to effectively stop hair loss or regrow hair in Frontal Fibrosing Alopecia, and more research is needed.

The study found that treatment improved hair condition in patients with Fibrosing Alopecia in a Pattern Distribution in Chile.

Frontal Fibrosing Alopecia is a slowly progressing hair loss condition, likely underdiagnosed, with ineffective treatments, needing more research to understand it fully.

Histopathological confirmation is crucial for accurately diagnosing challenging alopecia areata cases.

People with alopecia have a higher risk of thyroid cancer.

Lower PPARγ levels and specific gene variations are linked to more severe Frontal Fibrosing Alopecia.

A young man with an unusual type of scarring hair loss suggests a possible new variant of a known scalp condition.

Women with scarring alopecia are less likely to have used hormone replacement therapy or oral contraceptives compared to those with female pattern hair loss.

A 70-year-old woman with a rare skin condition improved after treatment with topical steroids and acitretin.

The document concludes that recognizing specific histological features of different nonscarring alopecias is crucial for accurate diagnosis and understanding hair loss progression.

Combining mometasone furoate cream with adapalene gel is safer and more effective for hair regrowth in alopecia areata than using the cream alone.